摘要
Hepatocellular carcinoma remains a prominent cause of cancer-related mortality globally.Transarterial yttrium-90 radioembolization is a versatile therapy and plays an important role in the treatment of hepatocellular carcinoma.This review summarizes the establishment of radioembolization in the hepatocellular carcinoma treatment paradigm,treatment considerations across cancer stages,and recent advances in evidence.
